Switzerland has reached a Mutual Recognition Agreement (MRA) with the United States for good manufacturing practice (GMP) inspections, which will facilitate and decrease administrative barriers in the exchange of pharmaceutical products between the two countries which will further strengthen the supply chain.Continue reading Switzerland has reached a Mutual Recognition Agreement with the US
1) General background information
As a consequence of the failed MRA between CH and the EU, EU certificates (i.e., medicinal products with SQS certificate) which were issued by the respective Swiss body, shall no longer be recognized in the EU and an EU representative is required.
Swiss Medtech companies have recently engaged national associations in order to take action against the so-called SQS ban by the EU Commission.
Dear pharma members
Germany has recently published a court decision with major impact on the pharma supply chain (commercial and clinical) in the EU Member States:Continue reading WEBINAR – Pharma news: German court decision – Sale of drugs from a Swiss company and new EU requirements